Table 2 Univariate analyses of overall survival in CNLC stage IIIb HCC patients (n = 150).

From: Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study

 

OR (95%CI)

P value

Gender (Male)

2.123 (0.663–6.799)

0.205

Age over 60 years

1.017 (0.574–1.803)

0.953

With HBV infection

1.125 (0.509–2.486)

0.77

Lymph node metastasis

0.934 (0.552–1.581)

0.799

Lung metastasis

1.493 (0.856–2.603)

0.158

Bones metastasis

0.902 (0.425–1.912)

0.788

Adrenal gland metastasis

0.782 (0.244–2.508)

0.679

Abdominal cavity metastasis

0.917 (0.481–1.746)

0.791

BCLC stage C

0.747 (0.318–1.756)

0.504

With portal vein invasion

1.831 (1.080–3.104)

0.025

With hepatic vein invasion

0.570 (0.206–1.580)

0.28

Effective first-line treatment

0.541 (0.302–0.968)

0.039

Receive surgical treatment

0.188 (0.059–0.602)

0.005

Back to article page